DarioHealth ( (DRIO) ) has released its Q4 earnings. Here is a breakdown of the information DarioHealth presented to its investors.
DarioHealth Corp. is a leading digital health company that provides a user-centric, multi-chronic condition digital therapeutics platform aimed at revolutionizing chronic condition management through data-driven interventions and personalized care.
In its latest earnings report, DarioHealth announced a significant 32.9% increase in full-year 2024 revenue, reaching $27 million, driven by its B2B2C channel and strategic acquisitions, notably Twill Inc. The company also highlighted a substantial increase in recurring revenues and a decrease in operating losses, reflecting improved financial performance and business momentum.
Key financial highlights include a 398% year-over-year increase in recurring revenues from the B2B2C business, a gross profit margin exceeding 80% in this segment, and a notable reduction in operating losses. The acquisition of Twill has strengthened Dario’s market position, contributing to a comprehensive digital health platform that addresses multiple chronic conditions. The company also secured 36 new clients in 2024, expanding its client base to 83 and forecasting a 50% net client growth in 2025.
Looking ahead, DarioHealth aims to achieve operational cash flow breakeven by the end of 2025, supported by continued revenue growth and cost management strategies. The company is focused on expanding its reach into mid-sized employers and enhancing its product offerings to align with healthcare cost reduction goals, positioning itself for sustained growth in the evolving digital health landscape.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com